PTU - Polskie Towarzystwo Urologiczne
list of articles:

ASSESSMENT OF PLASMA SIALIC ACID CONCENTRATION IN PATIENTS WITH GENITOURINARY TUMOURS
Article published in Urologia Polska 1990/43/1.

authors

Romuald Zdrojowy, Tomasz Szydełko, Bogdana D±browska
Z Katedry i Kliniki Urologii Akademii Medycznej we Wrocławiu
Kierownik Kliniki: doc. dr hab. med. J. Lorenz

summary

In 45 cases of genitourinary tumours the serum levels of sialic acid were de­termined and a statistically significant rise was found in the concentration of this compound in relation to controls.

references

  1. 1. Dnistrian AM., Schwartz M. K,; Plasma lipid ? bound sialic acid and car-
  2. cinoembrionic antigen in cancer patients. Clin. Chem., 1981, 27, 1737. ? 2. Dun-
  3. zendorfer B., Katopodis N., Dnistrian A. N., Stoch C. C, Schwartz M. K., Whitmore
  4. W. F.: Plasma lipid bound sialic acid in patients with prostate and bladder cancer.
  5. J. Urol, 1981, 19, 194. ? 3. Hogan ? Ryan A., Fennelly J.J., Jones M., Cantwell B.,
  6. Duffy M. J.: Serum sialic acid and CEA concentrations in human breast cancer.
  7. Brit. J. Cancer, 1980, 41, 587. ? 4. Horgan I. E.: Total and lipid ? bound sialic
  8. acid levels in sera from patients with cancer. Clin. Chim. Acta, 1982, 118, 327. ?
  9. 5. Kafka V., Musil J.: The use of serial determination of blood serum glucopro-
  10. teins for indirect evidence of the sensivity and resistance of malignant tumor
  11. cells to clinical chemotherapy. Neoplasma, 1977, 24, 101. ? 6. Katopodis N., Hirs-
  12. haut Y., Geller N. L., Stoch C. C: Lipid associated sialic acid test for the detec­
  13. tion of human cancer. Cancer Res., 1982, 42, 5270. ? 7. Katopodis N., Stock C. C:
  14. Improved method to determine lipid ? bound sialic acid in plasma or serum. Res.
  15. Commun. Chem. Pathol. Pharmacol., 1980, 30, 171. ? 8. Khadaphar S. V., Sheth
  16. N. A., Bhide S. V.; Independence of sialic acid levels in normal and malignant
  17. growth. Cancer Res., 1975, 35, 1520. ? 9. Mackbeth R. A., Bekesi J. B.: Plasma
  18. glycoproteins in yarious disease states including carcinoma. Cancer Res., 1962, 22,
  19. 1170. ? 10. Moss A.J., Bissada N.K., Boyd C.M., Hunter W.C.: Significance of protein ? bound neuraminic acid levels in patients with prostatic and bladder carcinoma. Urology, 1979, 13, 182.
  20. 11. Shamberger R. J.: Serum sialic acid in normals and in cancer patients.
  21. .J. Clin. Chem. Clin. Biochem., 1984, 22. 647. ? 12. Silver H.K., Karim K. A., Archi-
  22. bald E. L., Salinas F. A.: Serum sialic acid and sialyltransferase as monitors of
  23. tumor burden in malignant melonoma patients. Cancer Res., 1979, 39, 5036. ?
  24. 13. Tadeusiah W., Sadlowska B.. Krawczyński M.J.: Prosta metoda pomiaru stę­
  25. żenia kwasu sialowego w surowicy jako markera schorzeń nowotworowych. Pol.
  26. Tyg. Lek., 1987, 42, 845. ? 14. Tomaszewski L.: Markery biochemiczne choroby no­
  27. wotworowej. Pol. Tyg. Lek., 1986, 41, 1091.